Welcome to Therawis

Our mission is to combine highly innovative and novel diagnostics with effective therapeutics in oncology:

”The theranostic approach”

therascreen PITX2 RGQ PCR Kit (QIAGEN) is a novel clinically validated CE-IVD assay to determine the level of PITX2 methylation which helps predicting patient outcome to anthracycline-based chemotherapy and may help improve therapy decision-making.

Contact:

Therawis Pharma GmbH

Therawis Diagnostics GmbH

Grillparzerstrasse 14

81675 Munich Germany

Tel.: +49 (0) 89 41 42 45 57 0

Fax. +49 (0) 89 41 42 45 57 40

E-Mail: info@therawis.com

Website: http://www.therawis.com

 

Where to meet us:

< 2018 >
September
  • 08

    All day
    2018.09.08-2018.09.12

    On behalf of the European Society of Pathology and the Spanish Society of Pathology we would like to invite you to Bilbao, Spain to attend the 30th European Congress of Pathology (ECP 2018).

    Presenter: tba

© 2018 Therawis - All Rights Reserved